|
1
|
Bombonati A and Sgroi DC: The molecular
pathology of breast cancer progression. J Pathol. 223:307–317.
2011. View Article : Google Scholar :
|
|
2
|
André F and Zielinski CC: Optimal
strategies for the treatment of metastatic triple-negative breast
cancer with currently approved agents. Ann Oncol. 23(Suppl 6):
vi46–vi51. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin Y, Liu AY, Fan C, Zheng H, Li Y, Zhang
C, Wu S, Yu D, Huang Z, Liu F, et al: MicroRNA-33b inhibits breast
cancer metastasis by targeting HMGA2, SALL4 and Twist1. Sci Rep.
5:99952015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhong X, Coukos G and Zhang L: miRNAs in
human cancer. Methods Mol Biol. 822:295–306. 2012. View Article : Google Scholar
|
|
6
|
van Schooneveld E, Wildiers H, Vergote I,
Vermeulen PB, Dirix LY and Van Laere SJ: Dysregulation of microRNAs
in breast cancer and their potential role as prognostic and
predictive biomarkers in patient management. Breast Cancer Res.
17:212015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fang L, Du WW, Yang W, Rutnam ZJ, Peng C,
Li H, O’Malley YQ, Askeland RW, Sugg S, Liu M, et al: MiR-93
enhances angiogenesis and metastasis by targeting LATS2. Cell
Cycle. 11:4352–4365. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Smith AL, Iwanaga R, Drasin DJ, Micalizzi
DS, Vartuli RL, Tan AC and Ford HL: The miR-106b-25 cluster targets
Smad7, activates TGF-β signaling, and induces EMT and tumor
initiating cell characteristics downstream of Six1 in human breast
cancer. Oncogene. 31:5162–5171. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu J, Xu J, Wu Y, Chen Q, Zheng W, Lu X,
Zhou C and Jiao D: Identification of microRNA-93 as a functional
dysregulated miRNA in triple-negative breast cancer. Tumour Biol.
36:251–258. 2015. View Article : Google Scholar
|
|
10
|
Kolacinska A, Morawiec J, Pawlowska Z,
Szemraj J, Szymanska B, Malachowska B, Morawiec Z,
Morawiec-Sztandera A, Pakula L, Kubiak R, et al: Association of
microRNA-93, 190, 200b and receptor status in core biopsies from
stage III breast cancer patients. DNA Cell Biol. 33:624–629. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu S, Patel SH, Ginestier C, Ibarra I,
Martin-Trevino R, Bai S, McDermott SP, Shang L, Ke J, Ou SJ, et al:
MicroRNA93 regulates proliferation and differentiation of normal
and malignant breast stem cells. PLoS Genet. 8:e10027512012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
13
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moniz S and Jordan P: Emerging roles for
WNK kinases in cancer. Cell Mol Life Sci. 67:1265–1276. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang W and Luo YP: MicroRNAs in breast
cancer: Oncogene and tumor suppressors with clinical potential. J
Zhejiang Univ Sci B. 16:18–31. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wong DJ, Liu H, Ridky TW, Cassarino D,
Segal E and Chang HY: Module map of stem cell genes guides creation
of epithelial cancer stem cells. Cell Stem Cell. 2:333–344. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sarrió D, Rodriguez-Pinilla SM, Hardisson
D, Cano A, Moreno-Bueno G and Palacios J: Epithelial-mesenchymal
transition in breast cancer relates to the basal-like phenotype.
Cancer Res. 68:989–997. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kuperwasser C, Dessain S, Bierbaum BE,
Garnet D, Sperandio K, Gauvin GP, Naber SP, Weinberg RA and
Rosenblatt M: A mouse model of human breast cancer metastasis to
human bone. Cancer Res. 65:6130–6138. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Z, Yang CS, Nakashima K and Rana TM:
Small RNA-mediated regulation of iPS cell generation. EMBO J.
30:823–834. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Foshay KM and Gallicano GI: miR-17 family
miRNAs are expressed during early mammalian development and
regulate stem cell differentiation. Dev Biol. 326:431–443. 2009.
View Article : Google Scholar
|
|
22
|
Fan M, Sethuraman A, Brown M, Sun W and
Pfeffer LM: Systematic analysis of metastasis-associated genes
identifies miR-17-5p as a metastatic suppressor of basal-like
breast cancer. Breast Cancer Res Treat. 146:487–502. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hossain A, Kuo MT and Saunders GF:
Mir-17-5p regulates breast cancer cell proliferation by inhibiting
translation of AIB1 mRNA. Mol Cell Biol. 26:8191–8201. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu Z, Willmarth NE, Zhou J, Katiyar S,
Wang M, Liu Y, McCue PA, Quong AA, Lisanti MP and Pestell RG:
microRNA 17/20 inhibits cellular invasion and tumor metastasis in
breast cancer by heterotypic signaling. Proc Natl Acad Sci USA.
107:8231–8236. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu XF, Zou J, Bao ZJ and Dong J: miR-93
suppresses proliferation and colony formation of human colon cancer
stem cells. World J Gastroenterol. 17:4711–4717. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang IP, Tsai HL, Hou MF, Chen KC, Tsai
PC, Huang SW, Chou WW, Wang JY and Juo SH: MicroRNA-93 inhibits
tumor growth and early relapse of human colorectal cancer by
affecting genes involved in the cell cycle. Carcinogenesis.
33:1522–1530. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang Q, Zou Z, Zou C, Zhang Q, Huang R,
Guan X, Li Q, Han Z, Wang D, Wei H, et al: MicroRNA-93 suppress
colorectal cancer development via Wnt/β-catenin pathway
downregulating. Tumour Biol. 36:1701–1710. 2015. View Article : Google Scholar
|
|
28
|
Xu YF, Mao YP, Li YQ, Ren XY, He QM, Tang
XR, Sun Y, Liu N and Ma J: MicroRNA-93 promotes cell growth and
invasion in nasopharyngeal carcinoma by targeting disabled
homolog-2. Cancer Lett. 363:146–155. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang H and Yan X: Cantharidin modulates
the E2F1/MCM7-miR-106b-93/p21-PTEN signaling axis in MCF-7 breast
cancer cells. Oncol Lett. 10:2849–2855. 2015.
|
|
30
|
Petrocca F, Vecchione A and Croce CM:
Emerging role of miR-106b-25/miR-17-92 clusters in the control of
transforming growth factor beta signaling. Cancer Res.
68:8191–8194. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lyu X, Fang W, Cai L, Zheng H, Ye Y, Zhang
L, Li J, Peng H, Cho WC, Wang E, et al: TGFβR2 is a major target of
miR-93 in nasopharyngeal carcinoma aggressiveness. Mol Cancer.
13:512014. View Article : Google Scholar
|
|
32
|
Xie J, Wu T, Xu K, Huang IK, Cleaver O and
Huang CL: Endothelial-specific expression of WNK1 kinase is
essential for angiogenesis and heart development in mice. Am J
Pathol. 175:1315–1327. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lai JG, Tsai SM, Tu HC, Chen WC, Kou FJ,
Lu JW, Wang HD, Huang CL and Yuh CH: Zebrafish WNK lysine deficient
protein kinase 1 (wnk1) affects angiogenesis associated with VEGF
signaling. PLoS One. 9:e1061292014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee BH, Chen W, Stippec S and Cobb MH:
Biological cross-talk between WNK1 and the transforming growth
factor beta-Smad signaling pathway. J Biol Chem. 282:17985–17996.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wilson FH, Disse-Nicodème S, Choate KA,
Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV,
Lipkin GW, Achard JM, et al: Human hypertension caused by mutations
in WNK kinases. Science. 293:1107–1112. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu BE, Stippec S, Chu PY, Lazrak A, Li XJ,
Lee BH, English JM, Ortega B, Huang CL and Cobb MH: WNK1 activates
SGK1 to regulate the epithelial sodium channel. Proc Natl Acad Sci
USA. 102:10315–10320. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tu SW, Bugde A, Luby-Phelps K and Cobb MH:
WNK1 is required for mitosis and abscission. Proc Natl Acad Sci
USA. 108:1385–1390. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zeng G, Gao L and Yu RK: Reduced cell
migration, tumor growth and experimental metastasis of rat F-11
cells whose expression of GD3-synthase is suppressed. Int J Cancer.
88:53–57. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhu W, Begum G, Pointer K, Clark PA, Yang
SS, Lin SH, Kahle KT, Kuo JS and Sun D: WNK1-OSR1 kinase-mediated
phospho-activation of Na+-K+-2Cl−
cotransporter facilitates glioma migration. Mol Cancer. 13:312014.
View Article : Google Scholar
|
|
40
|
Dbouk HA, Weil LM, Perera GK, Dellinger
MT, Pearson G, Brekken RA and Cobb MH: Actions of the protein
kinase WNK1 on endothelial cells are differentially mediated by its
substrate kinases OSR1 and SPAK. Proc Natl Acad Sci USA.
111:15999–16004. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Alves CC, Carneiro F, Hoefler H and Becker
KF: Role of the epithelial-mesenchymal transition regulator Slug in
primary human cancers. Front Biosci (Landmark Ed). 14:3035–3050.
2009. View Article : Google Scholar
|
|
42
|
Sun X, Gao L, Yu RK and Zeng G:
Down-regulation of WNK1 protein kinase in neural progenitor cells
suppresses cell proliferation and migration. J Neurochem.
99:1114–1121. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fulford L, Milewski D, Ustiyan V,
Ravishankar N, Cai Y, Le T, Masineni S, Kasper S, Aronow B,
Kalinichenko VV, et al: The transcription factor FOXF1 promotes
prostate cancer by stimulating the mitogen-activated protein kinase
ERK5. Sci Signal. 9:ra482016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hsu YL, Hung JY, Chiang SY, Jian SF, Wu
CY, Lin YS, Tsai YM, Chou SH, Tsai MJ and Kuo PL: Lung
cancer-derived galectin-1 contributes to cancer associated
fibroblast-mediated cancer progression and immune suppression
through TDO2/kynurenine axis. Oncotarget. 7:27584–27598.
2016.PubMed/NCBI
|
